With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...
Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...
Johnson & Johnson MedTech has received a go-ahead from the FDA to begin human clinical trials of its Ottava surgical robot, ...
NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through ...
Chronic Lower Back Pain (CLBP) market Research Report Covers, Future Trends, Past, Present Data and Deep Analysis ...
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, "Orchestra BioMed" or the "Company"), a biomedical innovation company accelerating high-impact technologies ...
20h
The global ageing population and growing awareness of the benefits of orthobiologic therapy are driving the size of the global orthobiologics market.
This growth is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) worldwide, alongside continuous ...
Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery, is proud to announce the appointment ...
This includes a study to evaluate LockeT in patients that require large-bore venous access such as those used with the Micra pacemakers from Medtronic, the Watchman devices from Boston Scientific, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback